Professor Keertan Dheda
MBBCh FCP(SA) FCCP PhD (Lond) FRCP (Lond)
Professor
of Mycobacteriology and Global Health
Keertan Dheda holds a joint appointment between the LSHTM (Professor of Mycobacteriology and Global Health) and the University of Cape Town (UCT), where is the Director of the Centre for Lung Infection and Immunity. After graduating at the University of Witwatersrand in 1992 (Certificate of Merit) he then completed UK and EU-accredited training in Respiratory Medicine in London. He graduated with a PhD from UCL in 2005 through a British Lung Foundation Fellowship award.
Affiliations
Centres
Teaching
Keertan mentors Masters, PhD, and post doctoral trainees, and teaches on specific courses and seminars but does not do regular face-to-face teaching at the LSHTM. From a global health perspective, he has established an international collaborative network and a research programme in which several Masters and PhD students are currently enrolled. He is currently or has previously been involved in several capacity building-related global health programmes including those with UCL, New York University (NYU), South Western Medical School (Dallas), AIIMS (New Delhi, India), SVIMS (Tirupati, India), McGill (Canada), and several African (Zimbabwe, Zambia, Tanzania, Mozambique, Botswana and Malawi) and European countries (UK, Germany, Italy, Netherlands).
Research
His main research interests include the diagnosis, determinants, and outcomes of drug sensitive and drug resistant TB. He hold 5 patents related to new TB diagnostic, therapeutic or infection control technologies, one of which is currently being developed as a user-friendly test for extra-pulmonary tuberculosis. He serves on the editorial board of several journals including Lancet Respiratory Diseases (highest ranked in Respiratory Medicine; IF= 21.5), American Journal of Respiratory and Critical Medicine (second highest ranked in Respiratory Medicine; IF= ~16.5), Scientific Reports (Nature Group of journals), PLoS One, and the International Journal of Tuberculosis and Lung Disease, amongst others. He has been the recipient of several prestigious international awards including the 2010 International Union Against Tuberculosis and Lung Disease Scientific Award and the 2018 European Union-funded EDCTP Scientific Leadership Award. He is the founder and co-director of the charity, Free of TB, which seeks to promote the well-being of patients with TB.
Selected Publications
